The possible role of group specific component (Gc) (vitamin D-binding protein) in the clearance of cellular actin entering the circulation was examined with 125I-labeled Gc and actin injected into a rabbit model. Although filamentous F-actin is depolymerized primarily by plasma gelsolin, 2 90%
Introduction
Group specific component (Gc)' is an alpha2 glycoprotein in plasma (1) (2) (3) that was shown in 1975 to be the major carrier for vitamin D3 metabolites (D3) in a variety of mammalian species (4) . Gc has primarily been considered to be a component of the extracellular space. However, a protein physicochemically homologous to Gc (Mr 56,000, pl 4.8-5.0) has been described on the surface membrane of B lymphocytes where it codistributes with membrane immunoglobulin (5) , on T cells in relation to the Fc gamma receptor (6) , and also in the cytoplasm of many nucleated cells (7, 8) . Structural studies of plasma and cellular Gc have been limited to date, but recent sequencing of protein and full-length cDNA prepared from rat and human liver RNA has shown considerable sequence homology between Gc, and both albumin and alpha1-fetoprotein (9) (10) (11) (12) . Moreover, these proteins have been shown to be coded by genes present on chromosome 4 and may therefore constitute a protein family derived from a common ancestral gene (10, 11) .
The widespread occurrence ofGc in various animal species (13) suggests a crucial role for this protein, and no instance of plasma Gc deficiency has been found in more than 75,000 human samples tested (14) . However, the precise function(s) ofGc have not yet been elucidated. The transport ofvitamin D metabolites does not seem to be its only biological role, since < 5% of plasma Gc is complexed with D3 at any given time (15) , and no consistent relationship between Gc levels and the concentration of bound sterols has been demonstrated in health or disease (16, 17) . Moreover, although relevant studies have been limited, the reported plasma half-life of Gc appears considerably shorter both in humans [t1/2 = -2.5 d (18) ] and in rabbits [t1/2 = 1.7 d (19) ] than that of the major associated D3 metabolite, 25-hydroxy-cholecalciferol (25-(OH) D3), for which t1/2 = 11.3 d in the rabbit (19) .
Recently, a high affinity 1:1 molar ratio interaction has been demonstrated between Gc and the monomeric or globular G-form of actin (20) (21) (22) . Formation of this complex in vitro inhibits polymerization of actin to the filamentous or F-form, and also effects depolymerization of F-actin at stoichiometric concentrations (20, 21) . Gc may therefore be considered as a true G-actin-sequestering protein, and this has led to the suggestion that it acts as a scavenger of actin (20) . In contrast, plasma gelsolin (or brevin), the other major actin-depolymerizing protein in the extracellular space, primarily severs actin filaments at substoichiometric concentrations (23) (24) (25) (26) .
Although direct evidence of actin in the circulation is lacking, it appears likely that this protein would be released as a result of cell death, either as a physiological event related to normal tissue turnover, also termed apoptosis (27, 28) , or in an uncontrolled fashion due to environmental perturbation. Apoptosis seems to be a highly organized and relatively slow mechanism by which cells separate into fragments bounded by membrane, which are then phagocytosed by adjacent cells. The process of necrosis is more sudden and culminates in rupture of the plasma membrane (27) . This results in dispersion of cellular components into .the extracellular space, including presumably large amounts of actin, which represents 10-20% of total protein contained in most cells (29) . We have reported evidence indicating that a proportion of plasma or serum Gc is complexed with protein, which may include actin or fragments thereof, both in health and disease (30) (31) (32) (33) Rabbit '25I-Gc was used throughout for injection, MACi being administered either alone, or after incubation with saturating amounts of unlabeled G-actin (Gc:G-actin ratio = 1:2-1:10) for 15 min at 220C. For experiments involving 125I-F-actin, MCi in G-buffer (5 mM Tris, pH 7.5, 0.1 mM ATP, 0.1 mM CaC12, 0.5 mM DTT) was centrifuged together with unlabeled actin at concentrations above critical (I00,000 g for 60 min) to remove aggregated protein, and was then polymerized by addition of 100 mM KCI and 1 mM MgCI2 (F-buffer). After 30 min incubation, the samples were centrifuged for 60 min at 100,000 g at 22°C. Pelleting assays (39) showed that > 90% 251-actin was in the F-form. '25I-G-actin was prepared in one of two ways. First, the supernatant obtained by centrifugation at 100,000 g was used without further manipulation. Second, to investigate the possibility that such 125I-G-actin preparations contained altered actin, actin was subjected after radiolabeling to a cycle ofpolymerization/depolymerization by addition of F-buffer and centrifugation as above, followed by resuspension of the pellet obtained at subcritical concentrations (38) . As judged by pelleting assays (38) , these preparations both contained > 90% '251-actin in the G form, and gave equivalent results. Finally, for experiments involving '251-albumin, 200-400 MCi was injected.
Blood samples (2-3 ml) were collected, from vessels opposite to those used for injection, into evacuated glass tubes containing sodium heparin (Becton-Dickinson Co., Rutherford, NJ). Plasma was separated by centrifugation at 1000 g for 3 min at 22°C. An aliquot (100-1,000 ,ul) was counted in a gamma counter. Since complexes between Gc and actin have been found to be stable for at least 2 mo at -70°C, even after radiolabeling (unpublished observations), samples were occasionally stored frozen for up to a week when immediate assay was not feasible. Urine was collected from the bottom ofthe metabolic cage, and an aliquot (100-1,000 ul) was centrifuged in a glass tube (1,000 g for 3 min at 22°C) and counted in a gamma counter. Another aliquot was submitted to precipitation with 12.5% TCA, and the resulting pellet and supernatant were counted separately. For some experiments, male rabbits were sedated with 25 mg/kg body wt pentobarbital i.v., in order to allow the placement of catheter into the urinary tract to empty the bladder before the start of the experiment and to collect samples during the first 6 h after injection. Animals were killed at various times after injection of the labeled proteins by intracardiac injection of a lethal dose (250 mg) of pentobarbital.
Four rabbits were bilaterally nephrectomized under general anesthesia (20 mg kg-' ketamine from Bristol Laboratories, Syracuse, NY) and sterile surgical conditions. Labeled proteins were injected 1 h after completion ofsurgery, and plasma samples were obtained as described for normal animals. Survival of nephrectomized rabbits for up to 54 h was ensured by peritoneal dialysis initiated at 24 h after surgery. The catheter was placed intraperitoneally during nephrectomy, and two 100-ml exchanges of sterile dialysis fluid (5 mM MgCl2, 10 mM Ca lactate, 120 mM NaCl, 300 mM glucose, pH 7.4) were administered twice daily for 30-min periods. Antiserum to rabbit Gc. Polyclonal antisera were raised in sheep by immunization with purified rabbit Gc. Monospecificity of the antisera obtained was verified by immunoelectrophoresis (32). Moreover, such antisera were found to immunoprecipitate rabbit Gc in both native and complexed forms, as has been shown previously by rocket immunoelectrophoresis in the case of antisera to human Gc (32, 33, 35). Immunoprecipitation assays. 50 or 100 ,ul of samples were mixed with 50 or 100 Mil of antiserum monospecific for Gc and incubated for 45 min. Washed Staphylococcus aureus (Calbiochem-Behring Diagnostics, La Jolla, CA), 200 or 400 Ml respectively were added to the sample. After 30 min incubation the pellet was washed three times in PBS, and then resuspended in nonreducing SDS-PAGE sample buffer for 30 min. After centrifugation at 12,000 g for 5 min, the supernatant was removed, boiled for 5 min, counted and analyzed by SDS-PAGE. Chromatographic methods. Gel filtration was performed on Sephadex G-100 superfine in a column 7 X 880 mm-bed volume 135 ml-with 30 mM phosphate buffer, pH 7.0. After application of samples (0. 1-0.8 ml), elution was performed at a rate of6.9 ml h-' at 220C and 2.3-ml fractions were collected. The optical density profile (280 nm) was recorded.
Electrophoretic methods. Polyacrylamide gel electrophoresis (PAGE) was performed with and without SDS, using continuous (5-20%) gradient gels (22, 39). Where appropriate, the gels were dried and submitted to autoradiography. Fused rocket immunoelectrophoresis and crossed immunoelectrophoresis (CIEP) were carried out as described (35) using sheep antiserum to rabbit Gc and rabbit antiserum to human Gc, respectively (2% in agarose vol/vol). Flat bed thin layer isoelectric focusing was performed in non-denaturing conditions as reported (22).
Statistical analysis
Differences in the results obtained were analyzed by Wilcoxon's rank sum sign test.
Results
Characterization of labeled proteins. Purified rabbit and human '25I-Gc preparations were > 95% homogeneous as assessed by SDS-PAGE and autoradiography. Uncomplexed rabbit Gc was slightly larger (M, 58,000) than its human counterpart (Mr 56,000, Fig. 1 ), but the relative mobilities of both radioiodinated Gc preparations were identical to those observed with the homologous cold proteins (Fig. 1) . Moreover, IEF and PAGE in non-denaturing conditions demonstrated further evidence of retention of native properties in that rabbit '25I-Gc formed binary complexes with G-actin, and ternary complexes with G-actin:DNase ( Fig. 1 ) in a fashion similar to that found previously with human Gc (22). Rabbit 125I-Gc also formed complexes of 1:1 molar ratio with 2540H) D3 with a charge shift analogous to the anodal migration of human Gc:25-(OH) D3 complexes (35, Fig. 1 ). Similarly, 125i-F-actin (> 90% pelletable counts), '25I-G-actin (< 10% pelletable counts), and '25I-albumin were > 95% homogeneous and migrated on SDS-PAGE to positions indistinguishable from those of the native proteins (Fig. 1) ; '25I-G-actin preparations also retained the potential for polymerization (39) .
Initial plasma disappearance studies. A rapid decrease in total plasma counts was observed with all radiolabeled proteins immediately after injection, and the relationship with time was multiexponential. Subsequently, the rate of loss of total radioactivity stabilized and became log-linear with time. Based upon total counts, the mean half life (t1/2) calculated from this portion of the 125I-Gc curve was 28.8 h, a result not substantially different from the figure of 1.7 d reported earlier (19) ; similar calculations for '25I-actin and '25I-albumin gave figures of 19.5 h and 5.8 d, respectively. In parallel with the plasma decay profiles, examination of urine samples showed a more rapid appearance of counts in the case of 125I-Gc, 125i-Gc:G-actin, and '25I-actin, than for '25I-albumin, and examination of urine counts showed that < 1% appeared to be protein-bound as judged by precipitability with 12.5% TCA.
Examination ofplasma counts after gel filtration. Recent reports have demonstrated variable removal of covalently bound 125I from injected proteins, raising the possibility of inaccuracies in t/2 measurements for the relevant proteins (40, 41) . In view of this, experiments were performed to evaluate the proportions of 1251 counts circulating in free form, and protein-bound, as judged by gel filtration of samples obtained sequentially after injection. In the case of 125I-Gc and 1251_ Gc:G-actin, such analyses showed a clear initial reduction in the percentage of total 1251 counts found in the protein-containing fractions, from 2 95% at 5 min after injection to 65 and 63%, respectively, at 7 h (Table I) , although later observations showed stabilization or even a slight increase both for '25I-Gc and '25I-Gc:G-actin (Table I) . Parallel experiments with '25I-actin showed an even faster decline, to . 22% at 7 h. In contrast, very little reduction in the percentage of counts bound to protein was apparent in the case of '25I-albumin, with > 90% of plasma radioactivity remaining protein-bound throughout the entire time period tested.
Examination ofplasma counts after immunoprecipitation with anti-Gc. To examine the possibility that some proteinbound plasma counts might be unrelated to Gc, as a result of secondary iodination or reutilization (40, 41) , parallel studies involving specific immunoprecipitation were performed. Initial experiments verified the monospecificity of anti-Gc as assessed by immunoelectrophoresis. Moreover, when tracer 125I-Gc was added to serum samples in vitro, > 95% of the counts present were immunoprecipitated with anti-Gc, as against < 3% when nonimmune sheep serum was substituted for antiGc. Plasma samples from experiments involving '25I-Gc or 1251-Gc:G-actin were therefore examined after immunoprecipitation with anti-Gc. This showed a rapid time-dependent reduction in the percentage of counts immunoprecipitated with Gc in successive samples after injection. Moreover, the percentages of counts specifically brought down in relation to Gc were slightly but consistently lower than the percentages of counts protein-bound as judged by Sephadex G-I00 filtration (Table I ). For example, at 3 h after intravenous administration of '25I-Gc, 64% of counts were protein-bound as judged by gel filtration, whereas 42% were immunoprecipitable with anti- (Table I) . Plasma clearance of radiolabeled proteins. These results (Table I ) indicated the occurrence of substantial deiodination of '251I-Gc and '251-G-actin, and possible reutilization or secondary iodination of other unrelated proteins (40, 41) . All subsequent measurements of plasma clearance were therefore calculated with counts obtained by immunoprecipitation of samples with anti-Gc (125I-Gc and '251I-Gc:G-actin), or G-100 gel filtration (1251I-G-actin). This indicated that plasma clearances of 251-Gc, 1251I-Gc:G-actin, and 125I-G-actin were in fact substantially shorter than suggested on the basis of total plasma counts-17.2±2.9 h (n = 3), 15 .0±1.5 h (n = 3), and 5.3±0.5 h (n = 3), respectively (Fig. 2) .
Complexing showed that > 75% of counts were obtained in the pellet, whereas < 5% of counts were brought down in the absence of anti-Gc. Such immunoprecipitated material was examined by SDS-PAGE with autoradiography (Fig. 3 ). This demonstrated a radiolabeled band of Mr 43,000, and an additional band, Mr 38,000 not present in the apparently homogeneous preparation initially injected (Fig. 1) , which may represent a proteolytic fragment of actin, as has been described previously in vitro (37). These results extended previous findings obtained in normal humans with G-actin in vitro (35), in indicating that the introduction of actin culminates in complexing with Gc, even when actin is filamentous and undergoes initial depolymerization by interaction with plasma gelsolin. To investigate this point further, experiments were performed with addition of '25I-F-actin to human serum in vitro. Analysis of proteins binding actin was made by CIEP with antisera to whole human serum and Gc, and subsequent autoradiography (Fig. 4) . This showed that within 5 min most ofthe actin added (> 80%) had complexed to a protein with a2 mobility, which was immunoreactive with anti-Gc and showed the anodal shift upon com- plexing typical of this protein. Some radioactivity was also found in the form of a smudge at the origin (Fig. 4) .
Enhanced clearance of "'I5-G-actin after complexing with Gc in vivo. To examine the clearance of 1251-actin after complexing with Gc in vivo, sequential samples were subjected to G-100 chromatography. This showed a major and progressive alteration in the proportionation of 1251 counts between peaks at Mr 2 150,000 and 100,000 (cf. Fig. 3 ). Thus, in contrast to the preponderance of counts in the Mr 100,000 peak at 5 min, protein-bound 125i counts were equally distributed between the two peaks by 9 h, and detectable only in the macromolecular peak at 24 h. Although these results could have reflected instability ofthe Gc:G-actin interaction with progressive disruption of the complex, radioactivity was background in all other fractions. In addition, gel filtration of 5-min samples containing Gc:'25I-G-actin (1:1 molar ratio) after incubation at 370C in vitro for similar time periods up to 9 h showed no detectable evidence of dissociation. Overall, > 90% of counts in the 100,000-Mr peak had disappeared within 5 h. These findings were consequently consistent with formation of stable complexes between '25I-actin and Gc, and their rapid and progressive removal.
Enhanced clearance of '25I-Gc complexed with G-Actin. The plasma disappearance curves for '25I-Gc and '25I-Gc:Gactin at steady state did not reveal any very obvious differences (Fig. 2) . However, the initial phase of decay did appear to be slightly but consistently faster for '25I-Gc complexed with Gactin than for native '25I-Gc, both as judged by total 125I and counts obtained after immunoprecipitation with anti-Gc. The possibility of enhanced clearance of '25I-Gc once complexed was further examined by gel filtration of serial samples obtained after injection of 125I-Gc and '25I-Gc:G-actin (Fig. 5) . At 5 min after injection of '251-Gc, > 90% of protein-bound counts were found in a well-defined peak-apparent Mr 55,000. Conversely, 5 min after intravenous administration of '25I-Gc:G-actin, only . 25% of protein-bound counts were found in this peak, and > 75% were found as expected at an elution volume identical to that observed after injection of '25I-actin (M, 100,000) corresponding to Gc:G-actin complexes (cf. Fig. 3 ). Study of later 125I-Gc:G-actin samples (Fig.   5 ) demonstrated that counts related to the macromolecular Gc fractions declined considerably faster (> 90% within 5 h) than those in comparable fractions containing native Gc (P = 0.014), or in animals receiving native 125I-Gc (P = 0.01).
Moreover, the decrease in the native Gc peak appeared slightly slower in rabbits injected with '25I-Gc:G-actin than in animals T.-administered 1251I-Gc alone (Fig. 5) . These observations therefore suggested the possibility of processing of 125I-Gc:G-actin complexes in vivo, resulting in some shifting of 251I-Gc from the Mr 100,000 peak to a pool eluting at Mr 55,000. In addition, when 125I-Gc:G-actin was incubated with native plasma at 370C in vitro for up to 7 hrs and then subjected to chromatography, counts related to the 100,000 Mr peak decreased by < 5%, indicating that the reduction observed in vivo was not explicable simply on the basis of spontaneous dissociation of complexes between 125I-Gc and G-actin.
Clearance of '25I-Gc, '25I-Gc:G-actin and '251I-G-actin in nephrectomized rabbits. Since considerable excretion of counts was found in the urine after injection of '25I-Gc and 125I-actin, and similar renal localization of 1251 following administration of Gc has been noted in a previous study (19) , labeled proteins were injected into animals that had undergone bilateral nephrectomy. Peritoneal dialysis achieved removal of < 5% of total counts injected, and the 1251 counts in the dialysate were < 1% TCA-precipitable. Consistent with the absence of glomerular filtration, the number of free 1251 counts in the circulation increased progressively throughout the experiment. However, when samples were analysed by gel filtration or immunoprecipitation, the clearance curves for 125I-Gc, 125i.-{ actin, and 1251I-albumin were not significantly different from those observed in animals with functioning kidneys (Fig. 6 ). In addition, the pattern of tissue uptake was not substantially altered by nephrectomy.
Discussion
Within the last decade, two proteins have been described in the circulation that interact with actin in humans and in other vertebrate species. The first was described as a heat-sensitive protein able to decrease the staining of actin by anti-actin antibodies in cells (42) , and to sever or destabilize filaments of actin in ultrastructural or viscosimetry studies (23-26, 43). This protein was further isolated and characterized (93,000 mol wt) (25, 44) and termed plasma gelsolin in respect to its structural and functional similarity with cellular gelsolin, or brevin based on its action ofshortening actin filaments (25, 26, Gc are after immunoprecipitation with anti-Gc, whereas 125I-G-actin results are given following Sephadex G-100 gel filtration (Fig. 2) . The '25I-albumin data is in the form of total counts. Radioactivity is expressed in all three cases as a percentage of the cpm obtained in serum immediately following intravenous administration, and results
shown are from single animals injected with each labeled protein.
44-48). Plasma gelsolin displays both calcium-dependent and calcium-independent effects, and interacts with actin in a polymorphous fashion (49) , with each molecule possessing two distinct actin-binding sites (48, (50) (51) (52) (53) . At low plasma gelsolin:actin molar ratios, the actions of nucleating actin filament assembly, blocking the fast growing end of the filaments, and severing actin filaments, are all strongly affected by the presence of calcium (46, 50, (52) (53) (54) . The second plasma protein found to interact with actin was identified as Gc or vitamin D-binding protein (20, 21, 55) . Gc differs from plasma gelsolin in being less heat-labile; in addition, the interaction with actin is not calcium-dependent and occurs with a stoichiometry of 1:1. In addition, Gc appears to undergo high affinity interaction only with G-actin monomer (K, = 108 M-') (22) . Direct comparison of the interactions of Gc and plasma gelsolin with actin have revealed that the latter affects the rate constant ofactin depolymerization, whereas Gc does not (50) . These observations provide a powerful stimulus for further studies of the molecular mechanisms involved in the clearance of circulating actin, and more specifically concerning the possible role ofGc in its removal. The most immediate question concerns the protein(s) to which actin is bound following entry into the extracellular space. Although the possibility exists that some radiolabeled protein injected might have been damaged during preparation, the proportion appeared small based on physicochemical properties and ligand binding studies (Fig. 1) . In addition, although G-actin prepared by polymerization:depolymerization might have contained some oligomers, the results obtained with such recycled G-actin were equivalent to those found with nonrecycled actin.
With these provisos, the present investigation demonstrated, as indicated earlier in vitro (35) , that under the experimental conditions employed the majority of 125I-actin injected into the circulation was rapidly complexed with Gc, regardless of whether protein was administered in soluble G-or filamentous F-form. Since depolymerization ofF-actin is much slower with Gc than with plasma gelsolin, even at stoichiometric concentrations (50), the very rapid binding of 125I-actin monomers to Gc observed in this study following injection of 1251-Factin is likely to reflect initial depolymerisation of filamentous actin by plasma gelsolin (50, 56) . This would presumably require sequential interaction of actin with gelsolin and Gc, and although this possibility has not been extensively examined, some evidence consistent with this concept does exist. Thus, in vitro experiments with purified Gc, plasma gelsolin and actin have demonstrated that Gc:G-actin complexes do not appear to bind plasma gelsolin, but that Gc can remove at least one of the two monomers of actin bound to plasma gelsolin (56) . In the current experiments involving '25I-F-actin, the majority of counts appeared to complex rapidly with Gc as illustrated in vivo by gel filtration and immunoprecipitation and in vitro by CIEP; a small proportion was also found in relation to other protein (Figs. 3, 4) , which although not specifically tested, could possibly be plasma gelsolin (34) .
Certain other evidence also indicates different but complementary functions for these two circulating actin-binding proteins. Thus, Gc can bind monomers of actin even in the presence of an excess of plasma gelsolin (56) . Moreover, although much cellular actin released in the monomeric G-form is likely to be complexed with the major intracellular G-actin-sequestering protein, profilin (29), Gc displays higher apparent affin-ity for G-actin under defined conditions than does profilin, and can displace profilin from actin (39) . Furthermore, Gc apparently binds certain fragments ofactin in vitro and in vivo (37, 39 and Fig. 3, inset) . Interaction ofGc with G-actin is also not apparently compromised by the presence of other known ligands, such as vitamin D metabolites bound to Gc, and/or DNase complexed with actin (20) (21) (22) . Circulating Gc, which is present at relatively high concentrations (300-500 ,g ml-') is thus an ideal actin-sequestering protein in this compartment. Consequently, although plasma gelsolin is crucial for depolymerization of any F-actin present in the circulation, Gc may represent the final repository for the majority of actin once in monomeric form, and may thereby preserve the capacity of gelsolin to sever F-actin (34, 56) . It also appears possible that the amount of actin complexing with gelsolin in vivo may depend upon the level of saturation of Gc, which will in turn be strongly influenced by the circulating level of this protein and the quantity of actin entering this compartment.
Since monomer actin seems to exist in the circulation mainly in the form of stable complexes with Gc, clearance of actin from the circulation would be expected to revolve around removal of Gc:G-actin complexes. Furthermore, disappearance of the latter would be expected to be more rapid than that of the native Gc molecule. Previous studies of the effects of complexing with 25 (OH)-D3 metabolites indicated that the t12 of Gc in this rabbit model (-1.7 d) was not perceptibly influenced (19) . On the other hand, more recent studies of the effects of actin complexing showed a considerable acceleration ofGc clearance (34) . This investigation highlighted certain important potential pitfalls in studies of radioiodinated proteins with short half-lives. In particular, inaccuracies were evident when clearance measurements were made without appropriate allowance for the rapid deiodination of 1251-Gc and the resulting increase in free 1251, and also the possible secondary iodination of other unrelated proteins (40, 41) . Although these phenomena may have occurred as a result ofdeiodinase activity in the circulation, they were much less marked in the case of 125I-albumin which had a slower turnover, and might therefore represent cellular uptake of the relevant protein. However, regardless of the mechanisms involved, the use of gel filtration and immunoprecipitation with anti-Gc did appear to permit more accurate analysis ofplasma decay of 1251 specifically bound to Gc and actin.
The results showed evidence that clearance of Gc:G-actin complexes from the circulation was substantially faster than that of native Gc in rabbits (> 90% within 5 h), as noted recently by Lind et al. (34) . Moreover, extremely rapid disappearance of such complexes was observed, regardless of whether counts were introduced on Gc or actin. Since the molecular sizes of native and complexed Gc are not substantially different, the much more rapid clearance of Gc, particularly after complex formation, than ofalbumin, argues in favor of removal by tissue uptake, rather than mere redistribution of protein into other compartments. The rapid deiodination seen for 1251-Gc and 1251I-G-actin is also consistent with cellular uptake. Moreover, the decay curve obtained when '251-Gc was administered together with G-actin was bimodal (Fig. 5) , with rapid clearance of '25I-Gc:G-actin, and apparently much slower disappearance of '251-Gc included in the 55,000 Mr peak corresponding to native Gc.
The mechanism(s) responsible for uptake of Gc complexes by tissues in vivo and their subsequent fate remain to be elucidated. A recent plasma disappearance study in rats did not find clear evidence ofenhanced clearance ofcomplexes, although it is of interest that the half life of native Gc was considerably more rapid than in rabbits (57) . On the other hand, the rapid appearance of large numbers of counts in various tissues studied after injection of '25I-Gc and I 31-Gc:G-actin in rabbits (19, 34) indicates that complexes are taken up substantially more rapidly, and that uptake is not limited to any single organ. It is possible that elements of the reticuloendothelial system may be involved, as is the case for another complex formed between plasma and released intracellular proteins, namely haptoglobin-hemoglobin (58) . This process may also involve a specific receptor site, since we and others have described the presence of a protein indistinguishable physicochemically and immunologically from Gc on the surface membrane of peripheral blood mononuclear cells (5, 6, 59, 60) , and it has been reported that mononuclear cells may bind Gc in vitro (61). Membrane Gc has also been reported on trophoblast cells (62) .
These considerations suggest a conceptual model whereby actin, as a major cell protein (29, 63) , is released into the extracellular space and rapidly removed under physiological circumstances. Actin filaments, which account for c. 50% of actin in nonmuscle cells and > 95% in muscle (29, 63) are rapidly fragmented by the severing action of plasma gelsolin, which increases their effective number and the number of monomeric actin molecules in equilibrium with such filaments (29, 63) . Gc then efficiently sequesters this expanded pool of monomeric actin through formation of stable high affinity 1:1 complexes, and might thereby prevent glomerular filtration of G-actin (58) . Most G-actin released is likely to be complexed with profilin, the major intracellular actin-sequestering protein (29, 63) . However, profilin is probably displaced by Gc (39) , resulting again in complexing of actin with Gc. Such complexes are then removed from the circulation by cellular uptake.
Based on this model, and on current knowledge concerning the concentration of Gc in the extracellular space (18) , the clearance of complexes, and average tissue content of actin (29, 63) , it is possible to calculate that at least 7 g actin could be cleared daily in normal humans. 
